Labang, Baby Boy .
HRN: 29-25-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/14/2026
07/14/2026
IV
80mg
Q8h
Neonatal Sepsis
Checking Final Appropriateness
Indication: Empiric Then Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes